ABB is extending its leadership in AI-powered autonomous mobile robotics with the launch of the Flexley Mover P603 platform ...

Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative breast cancer (TNBC), but could be heading for use in previously ...

AbbVie and Roche’s Venclexta is making headway as a second-line chronic lymphocytic leukaemia (CLL) treatment, and a new US filing could extend its use into the first-line setting. Roche has ...

Stay updated on the latest artificial intelligence news and developments with Fox Business. Get real-time insights and expert analysis on AI innovations, applications, and their impact on ...